Rhinorrhea Reduction Using BepreveTm Ophthalmic Solution 1.5% in a Clinical Model of Allergic Conjunctivitis: An Analysis of Pooled Data From Two Phase 3 Conjunctival Allergen Challenge (CAC) Clinical Trials

被引：0

作者：

Gow, J. A. ^{[1
]}

Williams, J. I. ^{[2
]}

Gomes, P. J. ^{[3
]}

Abelson, M. B. ^{[4
]}

McNamara, T. R. ^{[5
]}

机构：

[1] ISTA Pharmaceut Inc, Irvine, CA USA

[2] ISTA Pharmaceut Inc, Clin Res, Allergy, Irvine, CA USA

[3] ORA, Clin Res, Allergy, Andover, MA USA

[4] ORA, Andover, MA USA

[5] ISTA Pharmaceut Inc, Clin Res & Med Affairs, Irvine, CA USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期

关键词：

conjunctivitis; drug toxicity/drug effects; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1915

引用

页数：2

共 50 条

[1] Bepotastine Besilate Ophthalmic Solution 1.5% Produces Strong Clinical Benefit for Ocular Itching Immediately Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Clark, J. C.
Williams, J. I.
Gomes, P. J.
Abelson, M. B.
Gow, J. A.
McNamara, T. R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB256 - AB256
[2] TREATMENT OF OCULAR ITCHING WITH BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% FOR SUBJECTS WITH MORE SEVERE ITCHING RESPONSE IN A CONJUNCTIVAL ALLERGEN CHALLENGE (CAC) CLINICAL MODEL OF ALLERGIC CONJUNCTIVITIS
Kennedy, K. S.
Williams, J. I.
Gow, J. A.
Abelson, M. B.
McNamara, T. R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A129 - A129
[3] Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Tearing 16 Hours Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Williams, J. I.
McLaurin, E. B.
Kurata, F. K.
Abelson, M. B.
Gow, J. A.
McNamara, T. R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB257 - AB257
[4] Bepreve™ 1.5% Reduces Nasal Congestion for at Least 16 Hours: An Analysis of Integrated Data from Two Phase 3 Conjunctival Allergen Challenge (CAC) Clinical Trials
Gow, J. A.
Williams, J. I.
McNamara, T. R.
Gomes, P. J.
Abelson, M. B.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB38 - AB38
[5] Bepreve™ 1.5% Provides Clinically Meaningful Reduction in Allergen-Induced Ocular Itching for Subjects in an Analysis of Two Phase 3 Conjunctival Allergen Challenge (CAC) Clinical Trials
Williams, J. I.
Schooley, G. L.
Gow, J. A.
McNamara, T. R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB38 - AB38
[6] BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% PROVIDES A RAPID AND SUSTAINED REDUCTION IN OCULAR ITCH FOR SEVERELY ALLERGIC SUBJECTS FOLLOWING EXPOSURE TO RAGWEED OR GRASS POLLENS USING THE CONJUNCTIVAL ALLERGEN CHALLENGE (CAC) MODEL OF ALLERGIC CONJUNCTIVITIS
Munoz, M.
Williams, J. I.
Gow, J. A.
Schooley, G. L.
McNamara, T. R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A113 - A113
[7] Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model
Meier, Edward J.
Torkildsen, Gail L.
Gomes, Paul J.
Jasek, Mark C.
CLINICAL OPHTHALMOLOGY, 2018, 12 : 2617 - 2628
[8] Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Nonocular Composite Symptom (NOCS) Scores 16 Hours Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Gow, J. A.
Macejko, T. T.
Bergmann, M. T.
Meier, E.
Abelson, M. B.
Williams, J. I.
McNamara, T. R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB255 - AB255
[9] THE CONJUNCTIVAL ALLERGEN CHALLENGE (CAC) MODEL OF ALLERGIC CONJUNCTIVITIS - DOES ASSUMPTION OF A NORMAL DATA DISTRIBUTION INFLUENCE THE MEANS FOR EVALUATING CLINICAL AND STATISTICAL SIGNIFICANCE?
Kennedy, K. S.
Williams, J. I.
Gow, J. A.
Abelson, M. B.
McNamara, T. R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A129 - A130
[10] Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model
Netland, PA
Leahy, C
Krenzer, KL
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (06) : 717 - 723

← 1 2 3 4 5 →